Pathogenesis and treatment of human T-cell lymphotropic virus Type I-associated myelopathy

References

• Gessain A, Barin F, Vernant JC et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2,407–410 (1985).
   PubMed Web of Science ®Google Scholar
• Osame M, Usuku K, Izumo S et al. HTLV- I associated myelopathy, a new clinical entity [letter]. Lancetl, 1031–1032 (1986).
   Google Scholar
• Kubota R, Osame M, Jacobson S. Retrovirus: human T-cell lymphotropic virus Type I-associated diseases and immune dysfunction. In: Effects of Microbes on the Immune System. Cunningham MW, Fujinami RS (Eds), Lippincott Williams 8r Wilkins, Philadelphia, USA, 349–371 (2000).
   Google Scholar
• ••Excellent review on all aspects of HAM/ TSP.
   Google Scholar
• Kaplan J, Osame M, Kubota H. The risk of developing HTLV-I associated myelopathy/ tropical spastic paraparesis (HAM/TSP) among persons infected with HTLV-I. AIDS3, 1096–1101 (1990).
   Google Scholar
• Nagai M, Usuku K, Matsumoto W et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. j NeuroVirol. 4, 586–593 (1998).
   PubMed Web of Science ®Google Scholar
• Jeffery KJM, Usuku K, Hall SE et al. HLA alleles determine human T-lymphotropic virus-I(HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl Acad. Sci. USA 96, 3848–3853 (1999).
   PubMed Web of Science ®Google Scholar
• Jeffery KJ, Siddiqui AA, Bunce M et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T-cell lymphotropic virusType I infection. J. Immunol. 165,7278–7284 (2000).
   PubMed Web of Science ®Google Scholar
• Usuku K, Sonoda S, Osame M et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann. Neurol. 23, S143–150 (1988).
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of HTLV-I in tax gene and their association with different risk to HTLV-I-associated myelopathy/ tropical spastic parapraresis. j Infect. Dis. 182,1343–1349 (2000).
   PubMed Web of Science ®Google Scholar
• Izumo S, Ijichi T, Higuchi I, Tashiro A, Takahashi K, Osame M. Neuropathology of HTLV-I-associated myelopathy: a report of two autopsy cases. Acta Paediatr. Jpn 34, 358–364 (1992).
   PubMedGoogle Scholar
• Umehara F, Izumo S, Nakagawa M etal. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. j Neuropathol. Exp. Neurol. 52,424–430 (1993).
   Google Scholar
• Umehara F, Abe M, Koeeda Y, Izumo S, Osame M. Axonal damage revealed by accumulation of 13-amyloid precursor protein in HTLV-I-associated myelopathy. Neurol. Sci. 176,95-101 (2000).
   Google Scholar
• Aye MM, Matsuoka E, Moritoyo T et al. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/ tropical spastic paraparesis: Inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol. 100,245–252 (2000).
   PubMed Web of Science ®Google Scholar
• Kira J, Fujihara K, Itoyama Y, Goto I, Hasuo K. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. Neurol. Sci. 106,41-49 (1991).
   Google Scholar
• Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. j Neuropathol. Exp. Neurol. 53,72–77 (1994).
   PubMed Web of Science ®Google Scholar
• Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M. Activation of macrophage/microglias with expression of MRP8 and MRP14 is associated with the lesional activities in the spinal cord lesions in HTLV-I associated myelopathy. Neurol. 246,358–364 (1999).
   Google Scholar
• Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T-cells in cerebrospinal fluid from patients with HAM/TSP Ann. Neurol. 50,807-812 (2001).
   Google Scholar
• Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E. Common human T-cell leukemia virus Type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated Myelopathy/Tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect. Dis. 82,1044-1050 (2000).
   Google Scholar
• Mor F, Cohen IR. T-cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J Clin. Invest. 90, 2447–2455 (1992).
   Google Scholar
• Umehara F, Izumo S, Takeya M, Sato E, Osame M. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol. 91,343-350 (1996).
   Google Scholar
• Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. j Neuropathol. Exp. Neurol. 57,839–849 (1998).
   PubMed Web of Science ®Google Scholar
• Matsuoka E, Usuku K, Jonosono M, Takenouchi N, Izumo S, Osame M. CD44 splice variant involvement in the chronic inflammatory disease of the spinal cord: HAM/TSP j Neuroimmunol. 102,1–7 (2000).
   Google Scholar
• Kubota R, Umehara F, Izumo S et al. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. j Neuroimmunol. 53,23–29 (1994).
   PubMed Web of Science ®Google Scholar
• Matsuoka, E, Takenouchi H, Hashimoto K et al. Perivascular T-cells are infected with HTLV-I in the spinal cord lesions with HAM/TSP: double staining of immunohistochemistry and PCR in situ hybridization. Acta Neuorpathol. 96,340–346 (1998).
   PubMed Web of Science ®Google Scholar
• Moritoyo T, Reinhart TA, Moritoyo H et al. Human T-lymphotropic virus Type I-associated myelopathy and tax gene expression in CD4+ T-lymphocytes. Ann. Neurol. 40,84-90 (1996).
   Google Scholar
• Lehky TJ, Fox CH, Koenig S et al. Detection of human T-lymphotropic virus Type I (HTLV-I) tax mRNA in the central nervous system of HTLV-I-associated myelopathy /Tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37,167–175 (1995).
   PubMed Web of Science ®Google Scholar
• Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus Type 1. J Virol. 64, 5682–5687 (1990).
   Google Scholar
• Hanon E, Goon P, Taylor GP et al. High production of interferon gamma but not interleukin-2 by humanT-lymphotropic virus Type I-infected peripheral blood. B/ood98,721–726 (2001).
   Google Scholar
• Nakamura T, Furuya T, Nishiura Y, Ichinose K, Shirabe S, Eguchi K. Importance of immune deviation toward Thl in the early immunopathogenesis of human T-lymphotropic virus Type I-associated myelopathy. Med. Hypotheses 54, 777–782 (2000).
   PubMed Web of Science ®Google Scholar
• Goon PK, Hanon E, Igakura T et al. High frequencies of Thl-type CD4+ T-cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. B/ood99,3335–3341 (2002).
   Google Scholar
• Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic lymphocytes specific for HTLV-I in patients with HTLV-I associated neurological disease. Nature 348,245–248 (1990).
   Google Scholar
• Koenig S, Woods RM, Brewah YA et al. Characterization of MHC class I restricted cytotoxic T-cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol. 151,3874–3883 (1993).
   PubMed Web of Science ®Google Scholar
• Parker CE, Nightingale S, Taylor GP, Weber J, Bangham CR. Circulating antiTax cytotoxic T-lymphocytes from human T-cell leukemia virusType I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol. 68,2860–2868 (1994).
   Google Scholar
• Greten TF, Slansky JE, Kubota R et al. Direct visualization of antigen-specific T-cells: HTLV-1 Tax11-19- specific CD8+ T-cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc. Nat/Acad. Sci. USA 95,7568–7573 (1998).
   Google Scholar
• Bieganowska K, Hollsberg P, Buckle GJ et al. Direct analysis of viral-specific CD8+ T-cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T-cell lymphotropic virus-associated myelopathy. j Immunol. 162,1765–1771 (1999).
   PubMed Web of Science ®Google Scholar
• Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S. Increased activated human T-cell lymphotropic virus Type I (HTLV-I) Tax11-19-Specific memory and effector CD8+ cells in patients with HTLV-
   Google Scholar
• •• I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. Infect. Dis. 183, 197–205 (2001).
   Google Scholar
• Umehara F, Nakamura A, Izumo S et al. Apoptosis of T- lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. .1. NeuropathoL Exp. NeuroL 53, 617–624 (1994).
   Google Scholar
• Biddison WE, Kubota R, Kawanishi T et al. Human T-cell leukemia virus Type I (HTLV-B-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete pro-inflammatory cytokines, chemokines and matrix metalloproteinase. j Immunol 159, 2018–2025 (1997).
   PubMed Web of Science ®Google Scholar
• Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S. Demonstration of human T lymphotropic virus Type I (HTLV-I) tax- specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. .1. Immunol 161, 482–488 (1998).
   Google Scholar
• Hanon E, Stinchcombe JC, Saito M et al. Fratricide among CD8+ T-lymphocytes naturally infected with human T-cell lymphotropic virus Type I. Immunity13, 657–664 (2000).
   PubMed Web of Science ®Google Scholar
• Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S. CD8+ T-cells are an in vivo reservoir for human T-cell lymphotropic virus Type I. Blood 98, 1858–1861 (2001).
   Google Scholar
• Hara H, Morita M, Iwaki T et al. Detection of human T lymphotrophic virus Type I (HTLV-I) proviral DNA and analysis of T-cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. .1. Exp. Med. 180, 831–839 (1994).
   Google Scholar
• Nagai M, Yashiki S, Fujiyoshi T et al. Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens. .1. Neuroimmunol 65, 97–105 (1996).
   Google Scholar
• Hausmann S, Biddison WE, Smith KJ et al. Peptide recognition by two HLA-A2/ Tax11-19-specific T-cell clones in relationship to their MHC/peptide/TCR crystal structures. .1. ImmunoL 162, 5389–5397 (1999).
   Google Scholar
• Levin MC, Krichavsky M, Berk J et al. Neuronal molecular mimicry in immune-mediated neurologic disease. Ann. Neurol 44, 87–98 (1998).
   PubMed Web of Science ®Google Scholar
• Levin MC, Lee SM, Kalume F et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 8, 509–513 (2002).
   PubMed Web of Science ®Google Scholar
• •Suggests that an autoimmune mechanism relates to the pathogenesis of HAM/TSP.
   Google Scholar
• Wattel E, Vartanian JP, Pannetier C, Wain- Hobson S. Clonal expansion of human T-cell leukemia virus Type I-infected cells in asymptomatic and symptomatic carriers without malignancy. .1. Viral 69, 2863–2868 (1995).
   Google Scholar
• Taylor GP, Hall SE, Navarrete S et al. Effect of lamivudine on human T-cell leukemia virus Type 1 (HTLV-1) DNA copy number, T-cell phenotype and antitax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. j Virol 73, 10289–10295 (1999).
   PubMed Web of Science ®Google Scholar
• •Shows that PT inhibitors reduce HTLV-I proviral loads in HAM/TSP.
   Google Scholar
• Lehky TJ, Levin MC, Kubota R et al. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized antiTac. Ann. Neurol 44, 942–947 (1998).
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Nakahara K, Maruyama Y et al. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. j Neurovirol 2, 345–355 (1996).
   PubMed Web of Science ®Google Scholar
• ••Important study of treatments for HAM/TSP.
   Google Scholar
• Ijichi S, Eiraku N, Osame M et al. In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM). .1. NeuroimmunoL 23, 175–178 (1989).
   Google Scholar
• Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S. In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virusType I-associated neurologic disease: predominant expansion of CD8+ T-cells. Blood 98, 1506–1511 (2001).
   Google Scholar
• Izumo S, Goto I, Itoyama Y et al. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46, 1016–1021 (1996).
   PubMed Web of Science ®Google Scholar
• •Important double-blind, multicenter trial of IFN-a.
   Google Scholar
• Yamasaki K, Kira J, Koyanagi Y et al. Long- term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical tropical spastic paraparesis: a combined clinical, virological and immunological study. .1. NeuroL Sci. 147, 135–144 (1997).
   Google Scholar
• Matsuo H, Nakamura T, Tsujihata M et al. Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy. Lancet 2, 1109–1113 (1988).
   PubMed Web of Science ®Google Scholar
• Tsujino A, Nakamura T, Nishiura Y et al. Pentoxifylline downregulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy. Neuroimmunol 73, 191–196 (1997).
   Google Scholar
• Sommer N, Loschmann PA, Northoff GH et al. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med. 1, 244–248 (1995).
   PubMed Web of Science ®Google Scholar
• Hatae T, Hara H, Kobayashi T, Watanabe T. The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM). .1. NeuroL Sci. 148, 87–94 (1997).
   Google Scholar
• Kataoka A, Imai H, Inayoshi S, Tsuda T. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy. j NeuroL Neurosurg. Psychiatry 56, 1213–1216 (1993).
   PubMed Web of Science ®Google Scholar
• Yamano Y, Machigashira K, Ijichi S et al. Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP). j NeuroL Sci. 151, 163–167 (1997).
   PubMed Web of Science ®Google Scholar
• Nagasato K, Nakamura T, Ichinose K et al. Heparin treatment in patients with human T-lymphotropic virus Type I (HTLV-B-associated myelopathy: a preliminary study. NeuroL Sci. 115, 161–168 (1993).
   Web of Science ®Google Scholar
• Harrington WJ Jr, Sheremata WA, Snodgrass SR, Emerson S, Phillips S, Berger JR. Tropical spastic paraparesis/ HTLV-Lassociated myelopathy (TSP/ HAM): treatment with an anabolic steroid danazol. AIDS Res. Human Retroviruses7, 1031–1034 (1991).
   PubMed Web of Science ®Google Scholar
• Taylor PC, Williams RO, Maini RN. Immunotherapy for rheumatoid arthritis. CUIT: Opin. Immunot 13, 611–616 (2001).
   Google Scholar
• Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. I Neuroimmunol. 42, 127–130 (1993).
   PubMed Web of Science ®Google Scholar
• Nishimoto N, Yoshizaki K, Eiraku N eta]. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. Neurol Sci. 97, 183–193 (1990).
   Google Scholar
• Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc. Natl Acad. Sci USA 98, 14559–14564 (2001).
   Google Scholar